|
EML1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.628700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.27759963403685E-10 |
| Normal-vs-Stage2 |
4.634800E-01 |
| Normal-vs-Stage3 |
6.194800E-01 |
| Normal-vs-Stage4 |
1.641810E-01 |
| Stage1-vs-Stage2 |
5.822800E-03 |
| Stage1-vs-Stage3 |
5.99930000011462E-07 |
| Stage1-vs-Stage4 |
2.3269000060111E-09 |
| Stage2-vs-Stage3 |
6.850800E-01 |
| Stage2-vs-Stage4 |
1.215450E-01 |
| Stage3-vs-Stage4 |
9.729600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.592600E-04 |
| Normal-vs-AfricanAmerican |
1.271780E-01 |
| Normal-vs-Asian |
1.380040E-01 |
| Caucasian-vs-AfricanAmerican |
9.634800E-01 |
| Caucasian-vs-Asian |
2.450200E-01 |
| AfricanAmerican-vs-Asian |
8.681800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.191570E-02 |
| Normal-vs-Female |
4.37189999999976E-05 |
| Male-vs-Female |
2.908500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.999200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.772240E-04 |
| Normal-vs-Age(61-80Yrs) |
9.058100E-03 |
| Normal-vs-Age(81-100Yrs) |
7.979400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.933600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.843200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.109200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.875840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.991450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.014000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.276920E-03 |
| Normal-vs-Grade 2 |
4.58909998890533E-09 |
| Normal-vs-Grade 3 |
2.862600E-01 |
| Normal-vs-Grade 4 |
7.642400E-02 |
| Grade 1-vs-Grade 2 |
9.723300E-03 |
| Grade 1-vs-Grade 3 |
7.85929999969071E-07 |
| Grade 1-vs-Grade 4 |
1.25230000036503E-07 |
| Grade 2-vs-Grade 3 |
8.294800000197E-07 |
| Grade 2-vs-Grade 4 |
3.19289999994865E-08 |
| Grade 3-vs-Grade 4 |
1.159840E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.4764001132761E-10 |
| Normal-vs-ccB subtype |
4.601400E-01 |
| ccA subtype-vs-ccB subtype |
3.2513000003398E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.773600E-02 |
| Normal-vs-N1 |
7.669000E-01 |
| N0-vs-N1 |
2.549800E-01 |
|
|
